Hahn NM, Powles T, Massard C, et al. Updated efficacy and tolerability of durvalumab in locally advanced or metastatic urothelial carcinoma (UC). J Clin Oncol. 2017;35 (suppl; abstr 4525).
Lutetium-177 PSMA-617 zet belangrijke stap richting kliniek
nov 2018 | Uro-oncologie